# Human Papillomavirus Vaccine Market size to Reach USD 14.59 Billion by 2031 Driven by Expanding Immunization Programs - Link: https://www.thailand-business-news.com/pr-news/human-papillomavirus-vaccine-market-size-to-reach-usd-14-59-billion-by-2031-driven-by-expanding-immunization-programs - Published: 2026-04-23T22:51:00+07:00 - Author: MarketersMEDIA Newswire _Mordor Intelligence has published a new report on the human papillomavirus vaccine market, offering a comprehensive analysis of trends, growth drivers, and future projections. _ Hyderabad, Telangana, India, April 23, 2026 /MarketersMEDIA/ — **Introduction**  According to Mordor Intelligence, the [human papillomavirus vaccine market size](https://www.mordorintelligence.com/industry-reports/human-papillomavirus-vaccine-market?utm_source=marketersmedia) was valued at USD 8.98 billion in 2025 and is expected to grow to USD 9.73 billion in 2026, reaching USD 14.59 billion by 2031, with a CAGR of 8.39% during the forecast period. This consistent human papillomavirus vaccine market growth reflects the increasing awareness of HPV-related diseases and the role of preventive vaccination in reducing cancer burden.  The human papillomavirus vaccine industry is evolving with support from public health agencies and national immunization programs. Governments are expanding access to vaccines, especially in emerging economies, where awareness campaigns and funding support are improving vaccination rates. The introduction of simplified dosing schedules and broader eligibility criteria is also strengthening the human papillomavirus vaccine market forecast. Additionally, the shift toward gender-neutral vaccination policies is contributing to increased demand, helping improve human papillomavirus vaccine market share across different population groups.  **Key Trends in the Human Papillomavirus Vaccine Market**  **Expansion of National Immunization Programs**  One of the major human papillomavirus vaccine market trends is the expansion of government-led immunization initiatives. Countries across Asia-Pacific, Europe, and other regions are introducing HPV vaccines into their national vaccination schedules. This approach is helping improve accessibility and affordability, which directly supports human papillomavirus vaccine market growth. Public sector procurement continues to play a key role in increasing vaccine coverage, especially in low- and middle- income regions.  **Rising Adoption of Gender-Neutral Vaccination Policies**  The human papillomavirus vaccine industry is moving beyond female-focused vaccination strategies. Many countries are now recommending HPV vaccination for both males and females, recognizing the role of HPV in multiple cancers affecting different populations. This shift is increasing overall vaccine demand and strengthening the human papillomavirus vaccine market size by expanding the eligible population base.  **Increasing Preference for Multivalent Vaccines**  Another notable human papillomavirus vaccine market trend is the growing adoption of multivalent vaccines, particularly nonavalent formulations. These vaccines offer broader protection against multiple HPV strains, making them a preferred choice among healthcare providers and policymakers. This transition is positively influencing human papillomavirus vaccine market share, as demand shifts toward more comprehensive immunization options.  **Growth of Regional Manufacturing Capabilities**  The rise of local vaccine manufacturers in emerging markets is shaping the human papillomavirus vaccine industry. Regional production is helping reduce dependency on global supply chains and enabling cost-effective vaccine distribution. This trend is supporting human papillomavirus vaccine market growth by improving supply availability and encouraging competitive pricing strategies.  **Human Papillomavirus Vaccine Market Segmentation**  **By Vaccine Type**  * Bivalent vaccines  * Quadrivalent vaccines  * Nonavalent vaccines  **By Indication**  * Cervical cancer  * Anal cancer  * Penile cancer  * Oropharyngeal cancer  * Genital warts  * Others  **By Distribution Channel**  * Public  * Private  **By Age Group**  * Adults  * Pediatric  **By Geography**  * North America  * Europe  * Asia-Pacific  * Middle East and Africa  * South America  **Key Players in the Human Papillomavirus Vaccine Industry**  The human papillomavirus vaccine market is characterized by the presence of both global pharmaceutical companies and emerging regional manufacturers. These companies are focusing on expanding production capacity, improving vaccine accessibility, and strengthening their position in the competitive landscape.  **Market Landscape**  * Serum Institute of India Pvt. Ltd.  * Wantai BioPharm  * INOVIO Pharmaceuticals  * Merck & Co., Inc.  * GSK plc  **Conclusion**  The human papillomavirus vaccine market is expected to maintain steady progress as vaccination becomes an essential component of preventive healthcare. Increasing awareness of HPV-related diseases, combined with government initiatives and expanded vaccine access, will continue to support human papillomavirus vaccine market growth. The focus on early immunization and broader population coverage is expected to improve long-term health outcomes globally.  The human papillomavirus vaccine market forecast remains positive as healthcare systems prioritize disease prevention and invest in vaccination infrastructure. The growing presence of regional manufacturers and the introduction of cost-effective vaccines are likely to enhance accessibility, particularly in developing regions. This will help strengthen the overall human papillomavirus vaccine market size and ensure a more balanced distribution of vaccines worldwide.  **Industry Related Reports**  **Regenerative Medicine Market size:**  The Regenerative Medicine Market is projected to grow from USD 32.62 billion in 2025 to USD 91.94 billion by 2031, registering a CAGR of 18.19%. Growth is driven by increasing investments in stem cell research and rising demand for advanced therapies in chronic diseases.  **Get more insights:** [https://www.mordorintelligence.com/industry-reports/global-regenerative-medicines-market-industry?utm_source=marketersmedia](https://www.mordorintelligence.com/industry-reports/global-regenerative-medicines-market-industry?utm_source=marketersmedia) **Over the Counter (OTC) Drugs Market share:**  The OTC Drugs Market was valued at USD 195.96 billion in 2025 and is projected to reach USD 256.18 billion by 2031, growing at a CAGR of 4.57%. Rising consumer preference for self-medication and increasing availability of OTC products are key drivers of market growth.  **Get more insights:** [https://www.mordorintelligence.com/industry-reports/global-over-the-counter-otc-drugs-market-industry?utm_source=marketersmedia](https://www.mordorintelligence.com/industry-reports/global-over-the-counter-otc-drugs-market-industry?utm_source=marketersmedia) **About Mordor Intelligence:**  Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.  With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.  **For any inquiries or to access the full report, please contact:**  media@mordorintelligence.com  https://www.mordorintelligence.com/  Contact Info: Name: Mordor IntelligenceEmail: [Send Email](https://send.releasecontact.com/89189696) Organization: Mordor IntelligenceAddress: 11th Floor, Rajapushpa Summit, Nanakramguda rdPhone: 16177652493Website: [https://www.mordorintelligence.com/](https://www.mordorintelligence.com/) Release ID: 89189696 If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting [error@releasecontact.com](https://www.thailand-business-news.com/pr-news/error@releasecontact.com)( it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment. **Source** : [Human Papillomavirus Vaccine Market size to Reach USD 14.59 Billion by 2031 Driven by Expanding Immunization Programs](https://news.marketersmedia.com/human-papillomavirus-vaccine-market-size-to-reach-usd-1459-billion-by-2031-driven-by-expanding-immunization-programs/89189696?rand=206000) ```wp-block-verse The information provided in this article was created by MarketersMEDIA Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of Thailand Business News. ```